Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/30/24 16:01 | 9/30/24 | INMB | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO | 3 | P.ad | 252 | 7.05 | 0 | 36 | 3 | 1,286 | D | ||||||||||||||
9/16/24 20:48 | 9/12/24 | INMB | Health | BioPrd | Biological Products, (No Diag | Tesi Raymond Joseph | FL | DOT | P,CEO | 2 | P.ad | 248 | 7.42 | 0 | 33 | 2 | 1,554 | D | ||||||||||||||
6/26/24 08:00 | 6/25/24 | INMB | Health | BioPrd | Biological Products, (No Diag | Juda Scott | FL | D | 3 | P.d | 331 | 7.96 | 0 | 42 | 139 | 72 | I | |||||||||||||||
4/24/24 14:08 | 4/19/24 | INMB | Health | BioPrd | Biological Products, (No Diag | Lowdell Mark William | FL | OT | Chief Sc | 1 | P.ad | 120 | 8.32 | 0 | 14 | 1 | 1,511 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |